La catena delle opzioni mostra i dati chiave delle opzioni azionarie di AirSculpt Technologies a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per AirSculpt Technologies..

AirSculpt Technologies (NASDAQ:AIRS) Azioni, Catena delle Opzioni

AirSculpt Technologies

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies Inc

AirSwap - United States Dollar

Airship AI Holdings, Inc - Class A Common Stock

Airship AI Holdings Inc

Airspan Networks Holdings Inc

Airspan Networks Holdings Inc Warrants (01/11/2026)

Airspan Networks Holdings Inc Warrants - Class C (01/11/2026)

Maxim Group analyst Jason McCarthy downgrades Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) from Buy to Hold.

News

Downgrades

Analyst Ratings

GILD

Maxim Group Downgrades Gilead Sciences to Hold

Benchmark analyst David Williams maintains MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) with a Buy and raises the price target from $120 to $160.

Price Target

MTSI

Benchmark Maintains Buy on MACOM Technology Solns, Raises Price Target to $160

<a href="https://www.nytimes.com/2024/11/08/business/economy/house-committee-china-semiconductor-manufacturing.html" title="https://www.nytimes.com/2024/11/08/business/economy/house-committee-china-semiconductor-manufacturing.html">https://www.nytimes.com/2024/11/08/business/economy/house-committee-china-semiconductor-manufacturing.html</a>

AMAT

ASML

KLAC

LRCX

Reported Earlier, U.S. Lawmakers Seek Details On China Sales From Top Semiconductor Equipment Makers, Including KLA, Applied Materials, Lam Research, Tokyo Electron, And ASML

Needham analyst Mike Matson reiterates Axonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXNX#NASDAQ">AXNX</a>) with a Hold.

Reiteration

AXNX

Needham Reiterates Hold on Axonics

Keefe, Bruyette &amp; Woods analyst Vasundhara Govil maintains Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) with a Market Perform and raises the price target from $71 to $80.

Keefe, Bruyette & Woods Maintains Market Perform on Block, Raises Price Target to $80

JP Morgan analyst Reginald Smith upgrades Upstart Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) from Underweight to Neutral and raises the price target from $30 to $45.

Upgrades

UPST

JP Morgan Upgrades Upstart Hldgs to Neutral, Raises Price Target to $45

Keefe, Bruyette &amp; Woods analyst Kyle Voigt reiterates P10 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PX#NYSE">PX</a>) with a Market Perform and raises the price target from $12.5 to $13.

Keefe, Bruyette & Woods Reiterates Market Perform on P10, Raises Price Target to $13

WIIM

SOND

Sonder Holdings shares are trading higher after the company announced that it met all required closing conditions and is actively in the process of completing the convertible preferred equity transaction.

Keefe, Bruyette &amp; Woods analyst Timothy Switzer reiterates Priority Tech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTH#NASDAQ">PRTH</a>) with a Market Perform and raises the price target from $5 to $9.

PRTH

Keefe, Bruyette & Woods Reiterates Market Perform on Priority Tech Holdings, Raises Price Target to $9

Allstate Corp shares are trading higher after Jefferies maintained a Buy rating on the stock and raised its price target from $231 to $267.

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Palomar Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLMR#NASDAQ">PLMR</a>) with a Outperform and raises the price target from $117 to $120.

PLMR

Keefe, Bruyette & Woods Maintains Outperform on Palomar Hldgs, Raises Price Target to $120

Shares To Trade On Nasdaq Under Symbol JTAI With New CUSIP

Stock Split

JTAI

Jet.AI To Implement 1-For-225 Reverse Stock Split, Effective Nov. 12

JP Morgan analyst Doug Anmuth maintains Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) with a Neutral and raises the price target from $135 to $170.

EXPE

JP Morgan Maintains Neutral on Expedia Group, Raises Price Target to $170

Universal Health Servs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) short percent of float has risen 8.54% since its last report. The company recently reported that it has 1.53 million shares sold short, which is 3.56% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Universal Health Servs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731084320_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Universal Health Servs has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Universal Health Servs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Universal Health Servs's peer group average for short interest as a percentage of float is 4.17%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(UHS) - Analyzing Universal Health Servs's Short Interest

Inno Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INHD#NYSE">INHD</a>) short percent of float has risen 258.33% since its last report. The company recently reported that it has 34 thousand shares sold short, which is 6.45% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Inno Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731084315_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Inno Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Inno Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Inno Holdings's peer group average for short interest as a percentage of float is 2.97%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

INHD

Looking Into Inno Holdings's Recent Short Interest

Accenture's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) short percent of float has risen 3.12% since its last report. The company recently reported that it has 6.19 million shares sold short, which is 0.99% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.76 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Accenture Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731084310_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Accenture has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Accenture's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Accenture's peer group average for short interest as a percentage of float is 3.48%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Accenture's Recent Short Interest

SBGI

Sinclair And IIT Bombay Partner On Wireless Broadcast-to-Everything (B2X) Research; MoU To Enhance ATSC 3.0 Standard For Mobile, TV, And IoT Applications With 5G Integration And Low-Latency Datacasting

Chemed Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHE#NYSE">CHE</a>) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.

Buybacks

Chemed Authorizes An Additional $300M For Stock Repurchase

Keefe, Bruyette &amp; Woods analyst Timothy Switzer reiterates NewtekOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) with a Market Perform and raises the price target from $13 to $15.

NEWT

Keefe, Bruyette & Woods Reiterates Market Perform on NewtekOne, Raises Price Target to $15

HC Wainwright &amp; Co. analyst Robert Burns reiterates Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) with a Buy and maintains $5 price target.

PRLD

HC Wainwright & Co. Reiterates Buy on Prelude Therapeutics, Maintains $5 Price Target

Whit Mayo, an analyst from Leerink Partners, reiterated the Hold rating on Airsculpt Technologies, Inc. (AIRS – Research Report). The associated pr...

Hold Rating on Airsculpt Technologies Amidst Revenue Misses and Leadership Changes

AirSculpt started at neutral by BTIG, macroeconomic headwinds cited

Prior view was $180M-$190M, consensus $184.56M. The company is also maintaining its 2024 full year adjusted EBITDA outlook of $23M-$28M. Cites prel...

AirSculpt Technologies narrows  FY24 revenue view to $183M-$189M

AirSculpt revises annual revenue outlook

Analyst Whit Mayo of Leerink Partners reiterated a Hold rating on Airsculpt Technologies, Inc. (AIRS – Research Report), retaining the price target...

Airsculpt Technologies, Inc.: Hold Rating Maintained Amid Concerns Over Growth and Margin Pressure

InMode: A Deep Dive After Q3 Earnings

Reports Q3 revenue $42.54M, consensus $41.73M. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period ...

AirSculpt Technologies reports Q3 EPS (10c), consensus (5c)

Reaffirms FY24 adjusted EBITDA $23M-$28M; and Adjusted EBITDA to cash flow from operations conversion ratio of 50%. Expects 5 new centers to open i...

AirSculpt reaffirms FY24 revenue view $183M-$189M, consensus $185.23M

AirSculpt Technologies GAAP EPS of -$0.10, revenue of $42.5M

AirSculpt Technologies, Inc. (AIRS) Q3 2024 Earnings Call Transcript

AIRS

APYX

CUTR

INMD

RVNC

Penny Stocks

Press Releases

AIRS Investors Have Opportunity to Join AirSculpt Technologies, Inc. Securities Fraud Investigation with the Schall Law Firm

AirSculpt Technologies, Inc. (AIRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Legal

AirSculpt® Technologies, Inc. Announces Opening of Its New Center in Columbus, OH

AirSculpt® Technologies, Inc. Adds New Center In Deerfield, IL To Meet Chicago Market Demand

AirSculpt® Technologies, Inc. Announces Opening of Its New Center in Birmingham, MI

AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results

Earnings

AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results

Accolade

Agilon Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Biodesix

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

Castle Biosciences

DocGo

Enhabit

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Fulgent Genetics

InnovAge Holding

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

23andMe Holding

ModivCare

National Research Corporation - Common Stock

National Research

Nutex Health

OPKO Health

Performant Financial Corporation - Common Stock

Performant Finl

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Pennant Gr

SBC Medical Group Holdings Incorporated - Common Stock

Comments

AirSculpt Technologies

AirSculpt Technologies (AIRS) Opzioni

AirSculpt Technologies (NASDAQ:AIRS) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO